Taken together, the results show that ACADL significantly inhibits the migration and invasion ability of HCC cells, and decreases the normalized vascular leakiness, indicating that ACADL is essential for the suppression of HCC cell metastasis. Here, ACADL is linked to hepatocellular carcinoma.